The prolonged use of trimethoprim-sulphonamide in urinary infection.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D001772:Blood Cell Count; D001792:Blood Platelets; D004338:Drug Combinations; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage*; D006801:Humans; D007501:Iron / Q000097:blood / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D011743:Pyrimidines / Q000008:administration & dosage*; D012008:Recurrence; D012156:Reticulocytes; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D007501:Iron; D013420:Sulfamethoxazole